Remedial Health
Digitizing the pharmaceutical supply chain in Africa.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | N/A | $4.0m | Debt |
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 380 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Remedial Health operates in the pharmaceutical industry, primarily serving pharmacies, health institutions, and insurers in Nigeria. The company offers a tech-enabled supply chain solution that includes proprietary Patient Medication Records (PMR) software, inventory management, and private label medicines. By leveraging technology, Remedial Health aims to modernize the pharmaceutical market in Africa, which is plagued by counterfeit drugs and inefficiencies. The business model revolves around vendor-managed inventory, where clients only pay for stock when it is dispensed to patients, thereby reducing the financial burden of maintaining large inventories. Remedial Health also provides pharmacy benefits for insurers, helping them manage the cost and logistics of long-term medication for their clients. The company generates revenue through the sale of medicines and inventory management services. With a network of over 300 pharmacies and operations in 36 states in Nigeria, Remedial Health has served over 300,000 patients and deployed over 800,000 inventory units.
Keywords: pharmaceutical procurement, inventory management, PMR software, private label medicines, tech-enabled supply chain, pharmacy benefits, counterfeit drugs, Nigeria, health institutions, insurers.